Azura Ophthalmics Limited

Azura Ophthalmics Limited is a leading pharmaceutical company dedicated to delivering first-in-class ophthalmic keratolytics. With a deep understanding of ocular surface diseases and a commitment to innovative drug development, Azura Ophthalmics is focused on treating underserved ophthalmic conditions. Located at 5 Druyanov St, Tel Aviv, Tel Aviv 6314305, IL, Azura Ophthalmics combines ophthalmologic and dermatologic solutions to harness the unique properties of keratolytics, addressing the root causes of various ocular issues.

Azura Ophthalmics' differentiated approach and internally discovered pipeline of new chemical entities enable the company to develop a portfolio of first-in-class ophthalmic therapeutics designed to meet significant unmet needs. The company is committed to enhancing vision care through groundbreaking research and the development of advanced pharmaceutical solutions. Azura Ophthalmics' mission is to improve patient outcomes and quality of life by providing effective and innovative treatments for ophthalmic conditions.

Operating from its headquarters in Tel Aviv, Azura Ophthalmics Limited is poised for continued growth and innovation in the pharmaceutical industry. The company's dedication to excellence and its focus on addressing unmet needs make it a valuable partner in the healthcare community. We invite the manager of Azura Ophthalmics Limited to create a customized and exclusive company showcase and product listing on our platform to further highlight their contributions to the field of ophthalmic pharmaceuticals.